These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 386519)

  • 1. Pharmacology of platelet-suppressive agents.
    Wautier JL; Caen JP
    Semin Thromb Hemost; 1979; 5(4):293-315. PubMed ID: 386519
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical pharmacology of platelets.
    Packham MA; Mustard JF
    Blood; 1977 Oct; 50(4):555-73. PubMed ID: 332253
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiplatelet therapy (first of two parts).
    Weiss HJ
    N Engl J Med; 1978 Jun; 298(24):1344-7. PubMed ID: 651993
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro evaluation of inhibitors of platelet release and aggregation.
    Rosenberg JC; Sell TL
    Arch Surg; 1975 Aug; 110(8):980-3. PubMed ID: 168838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of halofenate and clofibrate on aggregation and release of serotonin by human platelets.
    Lin CY; Smith S
    Life Sci; 1976 Mar; 18(6):563-8. PubMed ID: 1263738
    [No Abstract]   [Full Text] [Related]  

  • 6. [Platelet aggregation inhibitors. Their possible use in pediatric pathology].
    Zannino L; Salvadori G
    Minerva Pediatr; 1979 Jan; 31(2):153-69. PubMed ID: 379581
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigation of the role of arachidonic acid in platelet function and mechanisms for suppression of prostaglandin biosynthesis.
    Huzoor-Akbar ; Ardlie NG
    Br J Haematol; 1978 May; 39(1):71-81. PubMed ID: 666979
    [No Abstract]   [Full Text] [Related]  

  • 8. Heparin opposes prostanoid and non-prostanoid platelet inhibitors by direct enhancement of aggregation.
    MacIntyre DE; Handin RI; Rosenberg R; Salzman EW
    Thromb Res; 1981 Apr 1-15; 22(1-2):167-75. PubMed ID: 6270842
    [No Abstract]   [Full Text] [Related]  

  • 9. On the mechanism of platelet aggregation induced by heparin, protamine and polybrene.
    Eika C
    Scand J Haematol; 1972; 9(3):248-57. PubMed ID: 4626630
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
    Jobin F
    Union Med Can; 1976 Aug; 105(8):1159-73. PubMed ID: 10662
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyperfunction of blood platelets and suppressive agents].
    Yasunaga K; Ryo T
    Rinsho Ketsueki; 1975 Apr; 16(4):396-407. PubMed ID: 1170359
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelets and contact activation of blood clotting. Influence of some aggregation inhibitors.
    Coccheri S; Alessandri M; De Rosa V
    Acta Med Scand Suppl; 1971; 525():253-6. PubMed ID: 5292097
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet interactions with the endothelium and the subendothelium: the role of thrombin and prostacyclin.
    Cazenave JP; Dejana E; Kinlough-Rathbone R; Packham MA; Mustard JF
    Haemostasis; 1979; 8(3-5):183-92. PubMed ID: 389756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The inhibition of thrombocyte aggregation in vitro and in vivo].
    Breddin K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(4):460-9. PubMed ID: 4193162
    [No Abstract]   [Full Text] [Related]  

  • 15. Halofenate: a potent inhibitor of normal and hypersensitive platelets.
    Colman RW; Bennett JS; Sheridan JF; Cooper RA; Shattil SJ
    J Lab Clin Med; 1976 Aug; 88(2):282-91. PubMed ID: 956686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet agents: rationale and results.
    Kelton JG
    Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
    [No Abstract]   [Full Text] [Related]  

  • 17. An overview of antiplatelet and antithrombotic drugs.
    Verstraete M; Dejana E; Fuster V; Lapetina E; Moncada S; Mustard JF; Tans G; Vargaftig BB
    Haemostasis; 1985; 15(2):89-99. PubMed ID: 3159632
    [No Abstract]   [Full Text] [Related]  

  • 18. [Platelet function inhibitors in peripheral arteriopathies].
    Strano A; Davì G; Cannizzaro S; Giubilato A
    Recenti Prog Med; 1986 Apr; 77(4):205-9. PubMed ID: 2872704
    [No Abstract]   [Full Text] [Related]  

  • 19. A biphasic effect of prostacyclin (PGI2) on platelet aggregation.
    Jørgensen KA; Dyerberg J; Stoffersen E
    Thromb Res; 1980 Sep; 19(6):877-81. PubMed ID: 6258262
    [No Abstract]   [Full Text] [Related]  

  • 20. Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.
    Moncada S; Korbut R
    Lancet; 1978 Jun; 1(8077):1286-9. PubMed ID: 78050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.